Typar TCV IM Injection 0.5 ml/vial

Typar TCV IM Injection 0.5 ml/vial Uses, Dosage, Side Effects, Food Interaction and all others data.

Trade Name Typar TCV IM Injection 0.5 ml/vial
Generic Typhoid conjugate vaccine
Weight 0.5 ml/vial
Type IM Injection
Therapeutic Class Vaccines, Anti-sera & Immunoglobulin
Manufacturer Renata Limited
Available Country Bangladesh
Last Updated: October 19, 2023 at 6:27 am
Typar TCV IM Injection 0.5 ml/vial
Typar TCV IM Injection 0.5 ml/vial

Uses

Typhoid Conjugate Vaccine is indicated for active immunization against infection caused by Salmonella typhi in infants, children, adolescents and adults aged >6 months to <45 years.

Dosage

Typar TCV IM Injection 0.5 ml/vial dosage

A single 0.5 mL dose of the vaccine should be administered intramuscularly in the deltoid muscle of upper arm if muscle mass is adequate for children 2 years and above, adolescents and adults. For infants and toddlers aged >6 months to <2 years of age, the vaccine should be administered intramuscularly in the vastus lateralis muscle on anterolateral aspect of thigh. This vaccine should not be injected into the gluteal area or in any areas where there may be a nerve trunk.

Side Effects

The most frequently reported local adverse events after administration of Biological E's Typhoid Vi Conjugate vaccine were Injection Site Pain (4.50%), Injection Site erythema (0.64%) and Injection site Swelling (0.32%). These usually occurred within first 48 hours and disappeared within 2-3 days. The most frequently reported systemic adverse events were Pyrexia (2.25%), Vomiting (0.96%), Headache (0.64%), Fatigue (0.64%), Arthralgia (0.32%) and Rash (0.32%). No vaccine-related serious adverse events (SAEs) were reported in the clinical trial.

Precaution

Do not administer intravenously, intradermally or subcutaneously.Typar TCV IM Injection 0.5 ml/vial protects against typhoid fever caused by Salmonella typhi. Protection is not conferred against Salmonella paratyphi and other non typhoidal Salmonellae.Adrenaline (epinephrine) injection, 1:1000 (1 mg/mL) must be immediately available in case of an acute anaphylactic reaction or any allergic reaction occurs due to any component of the vaccine. The vaccinee should remain under medical supervision for not less than 30 minutes after vaccination. Like all other vaccines, supervision and appropriate medical treatment should always be available to treat any anaphylactic reactions following immunization.

Interaction

As on date there is no clinical data on co-administration of this vaccine. Hence, Biological E's Typhoid Vi conjugate vaccine should not be mixed with any other vaccine or medicinal product. For concomitant administration use different injection sites and separate syringes.

Pregnancy & Breastfeeding use

Safety and effectiveness have not been established in pregnant women and in nursing mothers. It is not known whether the vaccine is excreted in human milk.

Contraindication

Hypersensitivity to any component of vaccine Pregnant & lactating women In case of fever and severe infection

Storage Condition

Store at +2°C to +8°C. Do not freeze. Discard if found frozen. Shake well before use. Keep out of reach of children.

Innovators Monograph

You find simplified version here Typar TCV IM Injection 0.5 ml/vial


*** Taking medicines without doctor's advice can cause long-term problems.
Share